FACTS ABOUT BFST STOCK PRICE REVEALED

Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs geared toward growing the horizons of cytokine-based immunotherapy, especially for cancers where cure options remain limited. Make use of the links below to learn additional about our portfolio of cytokine-based immunotherapy